Microtubule/Tubulin inhibitor, Eribulin mesylate, Purity ≥98%

Cat. No.: X24-08-YM225

Microtubule/Tubulin inhibitor, Eribulin mesylate, Purity ≥98%

Synonym: 441045-17-6; Halichrondrin B analog; B1939; E7389; ER-086526; Halaven; (1S,3S,6S,9S,12S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,33R,35R,36S)-20-[(2S)-3-Amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-dimethylidene-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-24-one; methanesulfonic acid

  • CAS Number: 441045-17-6
  • Compound CID: 17755248
Product Size
0.5 mg; 1 mg; 5 mg; 10 mg
Price
Datasheet
MSDS
Properties
Description
Eribulin mesylate is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting microtubule/tubulin.
Molecular Weight
826
Molecular Formula
C41H63NO14S
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
Eribulin mesylate is a cytoskeletal signaling inhibitor that plays a key role in inhibiting microtubule dynamics, leading to cell cycle arrest and apoptosis.
Storage
Store at -20ºC, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.